Novel Rutgers COVID vaccine may provide long-
Rutgers research team creates novel COVID vaccine that performs well in animals and now aims to team with pharmaceutical company to launch human trials.
Stay updated with breaking news from Derek Santangelo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rutgers research team creates novel COVID vaccine that performs well in animals and now aims to team with pharmaceutical company to launch human trials.
Animal studies indicate that a new COVID-19 vaccine developed at Rutgers may provide more durable protection against SARS-CoV-2 and its emerging variants than existing vaccines.
There is an urgent need for new and better treatments for people who suffer from Inflammatory Bowel Disease (IBD), a group of disorders that includes ulcerative colitis and Crohn's disease.
What Are the Differences Between the Pfizer and Moderna COVID-19 Vaccines? Here’s What We Know So Far Health.com 12/19/2020 Korin Miller Following a new emergency use authorization (EUA) from the US Food and Drug Administration, Americans now have two vaccine options in the fight against the COVID-19 pandemic: One from pharmaceutical company Pfizer and one from biotechnology company Moderna. Moderna's COVID-19 vaccine was officially authorized for emergency use Friday evening after an FDA panel recommended for the vaccine's approval. Pfizer's vaccine was granted its EUA o...